Fig. 5From: ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cellsPLX4032 and GSK2118436 induce upregulation of AMPK phosphorylation in BRAFV600E melanoma cells. Western blot analysis of A375, IGR37 and 501 Mel cells (BRAFV600E) treated with 1 μM of PLX4032 and 100 nM of GSK2118432 for the indicated time points. α-Tubulin was used as loading control, and one representative blot is shownBack to article page